TCR/B2M Knockout Jurkat Cell Line

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-78552	2 vials		-	-	3 - 15 business days*		10,964.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin).... more

Close menu

Product information "TCR/B2M Knockout Jurkat Cell Line"

This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRalpha/beta chains were genetically removed by CRISPR/Cas9 genome editing from Jurkat cells to generate the TCR Knockout Jurkat cell Line (BPS Bioscience #78539). These TCR knockout cells were then used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing.

Keywords:	CDABP0092,
Supplier:	BPS Bioscience
Supplier-Nr:	78552

Properties

Application:	Development of improved universal CAR-T or other effector cells
Species reactivity:	human

Database Information

KEGG ID :	K08055 \| Matching products
UniProt ID :	P61769 \| Matching products
Gene ID	GeneID 567 \| Matching products

Handling & Safety

Storage:	Liquid nitrogen
Shipping:	-80°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "TCR/B2M Knockout Jurkat Cell Line"

Write a review